In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Too many young people are prescribed pills for mental illness. Are we repeating history with GLP-1s?

A Super Bowl ad touting Hims & Hers Health Inc.’s copycat weight-loss drugs is getting pushback from the branded drugmakers’ ...

The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...

When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of ...

New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...

If you've seen an ad in your Instagram feed featuring Whoopi Goldberg promoting weight loss drugs, you probably shouldn't buy ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, ...